Regulation and marketing autorization

The World Health Organization, which recognizes the value of integrating traditional medicine, and in particular herbal medicines, into health systems, supports member states in deploying appropriate public policies, action plans and pharmacovigilance strategies. Among them, 124 countries have already adopted laws and regulations concerning herbal health products.
Marketing Authorization (MA) is one of the regulatory tools used to market products derived from traditional pharmacopoeia, known as Improved Traditional Medicines (ITMs).

The QUALITY network has observed an imbalance between the demand for ITMs and the number of marketed products meeting the criteria of quality, safety and efficacy. Based initially on an analysis of public policies and markets in Peru, West Africa and France, presented in a regulatory review, the network aims to support the development of ITMs. The latter is also based on scientific data and quality control methodology, which are two of the network’s other areas of focus.

MEMBER TEAMS

News

Rokia Sanogo receives the Prix Galien Afrique 2021 for her work in traditherapy

4 February 2022

The Prix Galien Afrique recognizes excellence and innovation. It is awarded for products, services and initiatives that are highly convincing or promising, in the field of innovative discoveries and therapies at the service of humanity. To learn more about this award, click here. For the category "Best traditherapy product", Pr Rokia SANOGO, member of the GDRI QUALITY, was awarded this prize on December 11, 2021 in Dakar (Senegal), by the President of the Republic of Senegal. For more information, click here.


First workshop of the nework QUALITY – 2021, December 15 and 16th

1 February 2022

The first workshop of our QUALITY network took place on December 15 and 16, 2021, by visioconference. Here is the detailed program.  

Tout afficher